CD37 Recombinant Monoclonal Antibody
-
中文名稱:CD37重組抗體
-
貨號:CSB-RA004928MA1HU
-
規格:¥1320
-
圖片:
-
IHC image of CSB-RA004928MA1HU diluted at 1:200 and staining in paraffin-embedded human tonsil tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-human polymer IgG labeled by HRP and visualized using 0.05% DAB.
-
-
其他:
產品詳情
-
產品描述:CSB-RA004928MA1HU CD37重組單克隆抗體是針對人源CD37抗原設計的高特異性科研工具。CD37作為四次跨膜蛋白家族成員,在B淋巴細胞表面特異性表達,參與調控細胞黏附、遷移及信號轉導,其異常表達與B細胞淋巴瘤等疾病密切相關。本抗體經ELISA及免疫組化(IHC)雙重平臺驗證,在IHC應用中可清晰顯示石蠟包埋組織中B淋巴細胞的膜定位特征,推薦使用稀釋度為1:50-1:200,能有效區分目標蛋白的組織分布差異。ELISA檢測體系顯示其具備出色的線性反應范圍,適用于體外樣本的定量分析。該產品可為B細胞發育分化研究、淋巴瘤微環境分析、免疫細胞表面標記物檢測等實驗提供可靠支持,尤其在探究B細胞相關疾病的分子機制、篩選潛在治療靶點及開發體外檢測方法等領域具有重要應用價值。通過嚴格的抗原親和純化工藝,確保批次間穩定性,適用于需要高重復性的長期研究項目。
-
Uniprot No.:
-
基因名:
-
別名:CD37 Recombinant Monoclonal Antibody
-
反應種屬:Human
-
免疫原:Recombinant Human CD37 protein
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
-
克隆類型:Monoclonal
-
抗體亞型:hIgG1
-
純化方式:Affinity-chromatography
-
克隆號:9H6
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式:Liquid
-
應用范圍:ELISA, IHC
-
推薦稀釋比:
Application Recommended Dilution IHC 1:50-1:200 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產品
靶點詳情
-
基因功能參考文獻:
- CD37 is a critical determinant of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone outcome in diffuse large B-cell lymphoma. PMID: 27760757
- Data indicate that cell differentiation antigen 37 (CD37) is well expressed and a potential drug target in acute myeloid leukemia (AML). PMID: 25934707
- The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model. PMID: 24445867
- Data indicate that enhanced antibody-dependent cell cytotoxicity (ADCC) is observed against chronic lymphocytic leukemia cells and is sustained at concentrations of SMIP-016(GV) as low at 5E(-6) microg/mL on cells expressing minimal CD37 antigen. PMID: 23883821
- Identify two tyrosine residues in tetraspanin CD37 directly mediating transduction of survival and apoptotic signals. PMID: 22624718
- In the absence of both CD37 and Tssc6, immune function is further altered when compared with CD37- or Tssc6-deficient transgenic mice, demonstrating a complementary role for these two molecules in cellular immunity. PMID: 20709950
- CD37 cross-linking on human T cells transduces signals that lead to complete inhibition of CD3-induced T cell proliferation. PMID: 14978098
- CD37 is important for dectin-1 stabilization in APC membranes and controls dectin-1-mediated IL-6 production. PMID: 17182550
- provide strong justification for CD37 as a therapeutic target and introduce small modular immunopharmaceuticals as a novel class of targeted therapies for B-cell malignancies PMID: 17440052
顯示更多
收起更多
-
亞細胞定位:Membrane; Multi-pass membrane protein.
-
蛋白家族:Tetraspanin (TM4SF) family
-
組織特異性:B-lymphocytes.
-
數據庫鏈接:
Most popular with customers
-
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-